Adipose tissue is a key regulator of energy balance playing an active role in
lipid storage as well as in synthesizing several
hormones directly involved in the pathogenesis of
obesity.
Obesity represents a peculiar risk factor for a growing list of
cancers and is frequently associated to poor clinical outcome. The mechanism linking
obesity and
cancer is not completely understood, but, amongst the major players, there are both chronic low-grade
inflammation and deregulation of
adipokines secretion. In
obesity, the adipose tissue is pervaded by an abnormal number of immune cells that create an inflammatory environment supporting
tumor cell proliferation and invasion.
Adiponectin (APN), the most abundant
adipokine, shows anti-inflammatory, anti-proliferative and pro-apoptotic properties. Circulating levels of APN are drastically decreased in
obesity, suggesting that APN may represent the link factor between
obesity and
cancer risk. The present review describes the recent advances on the involvement of APN and its receptors in the etiology of different types of
cancer.